This is a '''timeline of {{w|Schistosomiasis Control Initiative}}''', a non-profit initiative that works with governments in {{w|sub-Saharan Africa}}n countries to develop sustainable programmes against parasitic worm infections.

+

This is a '''timeline of {{w|Schistosomiasis Control Initiative}}''', a non-profit initiative that works with governments in {{w|sub-Saharan Africa}}n countries to create or scale up programs that treat schistosomiasis and {{w|soil-transmitted helminthiasis}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/>

−

+

==Big picture==

==Big picture==

Line 94:

Line 94:

|-

|-

| 2018 || || || "In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."<ref name="HOW YOUR MONEY IS SPENT"/> ||

| 2018 || || || "In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."<ref name="HOW YOUR MONEY IS SPENT"/> ||

+

|-

+

| 2019 || March || Funding || {{w|GiveWell}} updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/>

SCI selects six countries for full support: Uganda, Burkina Faso, Niger, Mali, Tanzania, and Zambia. The countries each propose a different implementation approach and management structure for their large-scale schistosomiasis control.[6]

The British Department for International Development awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.[1]

2014

Coverage

ACI reaches median coverage for schistosomiasis treatment at 69% in Malawi, 82% in Côte d'Ivoire, and 47% in Uganda.[12]

2014 – 2015

Coverage

SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.[1]

ACI reaches median coverage for schistosomiasis treatment at 81% in Mozambique, 93% in Zambia (2015), and 80% in Zanzibar.[12]

2015

Schistosomiasis is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.[11]

2015 – 2016

SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.[1]

2015 – 2016

Between April 2015 and March 2016

SCI spends around US$2.1 million in unrestricted funding and $0.8 million in restricted funding in Ethiopia during the period.[1]

2015 – 2016

Between April 2015 and March 2016

SCI reports having delivered 890,000 treatments in Uganda, out of 1.2 million planned treatments.[1]

GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).[12]

2017

January

Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.[14]

2017

GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.[15]

2018

"In Q4 2017, GiveWell allocated 100% of its discretionary fund to the SCI, totalling $5.6 million. It allocated a further $0.89 million to the SCI in Q1 2018, which was 30% of its discretionary fund for that period."[15]

2019

March

Funding

GiveWell updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.[1]